Drug or treatment

Bimekizumab clinical trials

• 6Clinical trials
• 16Countries

Newest trials

All recruiting trials (6)

• Bimekizumab by IV infusion versus subcutaneous injection for adults with psoriatic arthritis or axial spondyloarthritis

  This trial tests whether bimekizumab given by intravenous (IV) infusion behaves the same in the body as the usual subcutaneous injection in adults with psoriatic arthritis or axial spondyloarthritis.

  Recruiting at 65 sites Phase 1 UCB Pharma · Peoria, Arizona and 64 other locations · NCT07290036

• Bimekizumab for palmoplantar pustulosis (PPP)

  This trial tests whether bimekizumab helps adults with palmoplantar pustulosis and is safe compared with a placebo.

  Recruiting at 91 sites Phase 3 UCB Pharma · Birmingham, Alabama and 90 other locations · NCT07219420

• Comparing five advanced treatments for axial spondyloarthritis and psoriatic arthritis

  This project will see how well bimekizumab, risankizumab, guselkumab, upadacitinib, or a TNF inhibitor work for adults with axSpA or PsA who have just started one of these medicines, using medical records and patient surveys.

  Recruiting Adelphi Real World · Bath, Somerset · NCT07166315

• Assessing Bimekizumab Levels in Breast Milk of Nursing Mothers

  This study tests how much of the medication bimekizumab is found in the breast milk of mothers who have been using it for at least 12 weeks after giving birth to see if it's safe for their babies.

  Recruiting at 14 sites Phase 1 UCB Pharma · Santa Monica, California and 13 other locations · NCT06888193

• Evaluating Bimekizumab for Early Treatment of Plaque Psoriasis

  This study is testing a new treatment called bimekizumab to see if it works better than standard creams for people aged 18 to 45 with mild plaque psoriasis.

  Recruiting at 6 sites Phase 2 Centre Hospitalier Universitaire de Nice · Nice, Alpes-Maritimes and 6 other locations · NCT06742333

• Evaluating Bimekizumab for Pediatric Arthritis

  This study is testing a new medication called bimekizumab in children with certain types of arthritis to see if it is safe and effective for them.

  Recruiting at 21 sites Phase 3 UCB Pharma · Calgary and 22 other locations · NCT06668181

Quick answers

How many clinical trials of Bimekizumab are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 16 countries. The most sites are in Germany (4 trials), United Kingdom (3 trials), Canada (3 trials), France (3 trials), Poland (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →